- Clinical Characteristics of Primary Peritoneal Carcinoma
-
Roh SY, Hong SH, Ko YH, Kim TH, Lee MA, Shim BY, Byun JH, Woo IS, Kang JH, Hong YS, Lee KS
- KMID: 2166098
- Cancer Res Treat.
- 2007 Jun;39(2):65-68.
PURPOSE: The goal of this study was to determine the clinical and therapeutic characteristics of women with a primary peritoneal carcinoma (PPC). MATERIALS AND METHODS: A retrospective clinical study was conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Detection of Lung Cancer using MAGE A1-6 and SSX4 RT-PCR Expression Profiles in the Bronchial Wash Fluid
-
Lee KH, Shin KC, Lee CH, Jheon SH, Jeon CH
- KMID: 2166099
- Cancer Res Treat.
- 2007 Jun;39(2):69-73.
PURPOSE: Bronchial wash fluid may be a useful for detecting lung cancer. To increase the detection rates, we performed molecular analysis with using MAGE A1-6 and SSX4 RT-PCR on bronchial... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in Overall Survival When Colorectal Cancer Patients are Stratified into New TNM Staging Strategy
-
Oh HS, Chung HJ, Kim HK, Choi JS
- KMID: 2166097
- Cancer Res Treat.
- 2007 Jun;39(2):61-64.
PURPOSE: The purpose of this study is to determine whether the prognosis can be more precisely gauged by the revised 6th AJCC staging system and if this is suitable for... -
- CITED
-
- Close
- SHARE
-
- Close
- An Attempt for Combining Microarray Data Sets by Adjusting Gene Expressions
-
Kim KY, Kim SH, Ki DH, Jeong J, Jeong HJ, Jeung HC, Chung HC, Rha SY
- KMID: 2166100
- Cancer Res Treat.
- 2007 Jun;39(2):74-81.
PURPOSE: The diverse experimental environments in microarray technology, such as the different platforms or different RNA sources, can cause biases in the analysis of multiple microarrays. These systematic effects present... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Organizing Pneumonia Associated with Rituximab
-
Maeng CH, Chin SO, Yang BH, Kim SY, Youn HJ, Cho KS, Baek SK, Lee S
- KMID: 2166102
- Cancer Res Treat.
- 2007 Jun;39(2):88-91.
Rituximab is a human/murine chimeric anti-CD20 mono- clonal antibody used to treat CD20-positive B-cell non- Hodgkin's lymphoma (NHL). Although most of the adverse effects associated with rituximab are usually reversible... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Docetaxel and Cisplatin as First-line Chemotherapy in Patients with Recurrent or Metastatic Gastric Cancer
-
Kim KH, Jeung KJ, Kim HJ, Bae SB, Kim CK, Lee NS, Lee KT, Park SK, Won JH, Hong DS, Park HS
- KMID: 2166095
- Cancer Res Treat.
- 2007 Jun;39(2):49-53.
PURPOSE: Palliative chemotherapy for patients with recurrent or metastatic gastric cancer has been shown to have a survival benefit. Docetaxel monotherapy has achieved appreciable results for treating gastric cancer. We... -
- CITED
-
- Close
- SHARE
-
- Close
- The Chemopreventive Effect of Retinoids on Cellular NF-kappa B Activity Induced by NMU and NEU in Human Malignant Keratinocytes
-
Moon KY
- KMID: 2166101
- Cancer Res Treat.
- 2007 Jun;39(2):82-87.
PURPOSE: Retinoids have been shown to be effective in suppressing tumor development when chemical carcinogens such as N-nitroso-N-methylurea (NMU) and N- nitroso-N-ethylurea (NEU) were used to induce mammary tumors in... -
- CITED
-
- Close
- SHARE
-
- Close
- Autologous Stem Cell Transplantation using a Modified TAM Conditioning Regimen for Clinically Aggressive Non-Hodgkin's Lymphoma
-
Hong SH, Hong YS, Woo IS, Koh YH, Rho SY, Peak JY, Lee MA, Shim BY, Byun JH, Park JC, Lee JW, Min WS, Kim CC
- KMID: 2166096
- Cancer Res Treat.
- 2007 Jun;39(2):54-60.
PURPOSE: High-dose chemotherapy (HDT) and autologous stem cell transplantation (ASCT) have been used for the treatment of clinically aggressive non-Hodgkin's lymphoma (NHL). However, the superiority of specific conditioning regimens has... -
- CITED
-
- Close
- SHARE
-
- Close
